Blumeria graminis
(Redirected from Erysiphe graminis)
Blumeria graminis is a fungal pathogen that affects cereal crops, particularly barley and wheat. It is the causative agent of powdery mildew, a common disease of these crops.
Taxonomy
The species was first described by Swiss botanist Heinrich Anton de Bary in 1879. It belongs to the Erysiphales order of fungi, which are characterized by their powdery appearance. The genus Blumeria is named after German botanist Robert Hartig, who made significant contributions to the study of fungal diseases in plants.
Life Cycle
The life cycle of Blumeria graminis involves both sexual and asexual reproduction. The fungus overwinters as ascospores, which are released in the spring to infect new hosts. During the growing season, the fungus reproduces asexually through the production of conidia, which are spread by wind to infect other plants.
Disease Symptoms
Infected plants exhibit white, powdery patches on the leaves, stems, and heads. As the disease progresses, these patches darken and the plant may become stunted or die. Yield losses can be significant, particularly in years with high humidity and moderate temperatures, which favor the growth and spread of the fungus.
Management
Management of Blumeria graminis involves a combination of cultural practices, resistant varieties, and fungicides. Cultural practices include crop rotation and the removal of infected plant debris to reduce the amount of inoculum in the field. Resistant varieties have been developed through traditional breeding and genetic engineering. Fungicides are used to control the disease, but resistance to these chemicals is a growing concern.
Impact
Blumeria graminis is a major threat to cereal production worldwide. It is estimated to cause losses of up to 20% in wheat and barley crops each year. The economic impact of these losses is significant, affecting farmers' incomes and food security.
See Also
References
| This article is a stub. You can help WikiMD by registering to expand it. |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD